Cayir Salih, Volpi Tommaso, Toyonaga Takuya, Gallezot Jean-Dominique, Yanghong Yang, Sadabad Faranak Ebrahimian, Mulnix Tim, Mecca Adam P, Fesharaki-Zadeh Arman, Matuskey David
Yale University School of Medicine.
Res Sq. 2024 Jan 15:rs.3.rs-3846125. doi: 10.21203/rs.3.rs-3846125/v1.
Frontotemporal dementia (FTD) is a clinically and pathologically heterogeneous condition with a prevalence comparable to Alzheimer's Disease for patients under sixty-five years of age. Gray matter (GM) atrophy and glucose hypometabolism are important biomarkers for the diagnosis and evaluation of disease progression in FTD. However, limited studies have systematically examined the association between cognition and neuroimaging in FTD using different imaging modalities in the same patient group.
We examined the association of cognition using Montreal Cognitive Assessment (MoCA) with both GM volume and glucose metabolism using structural magnetic resonance imaging (MRI) and F-fluorodeoxyglucose positron emission tomography scanning ([F]FDG PET) in 21 patients diagnosed with FTD. Standardized uptake value ratio () using the brainstem as a reference region was the primary outcome measure for [F]FDG PET. Partial volume correction was applied to PET data to account for disease-related atrophy.
Significant positive associations were found between whole-cortex GM volume and MoCA scores (r = 0.461, p = 0.035). The association between whole-cortex [F]FDG and MoCA scores was not Significant (r = 0.374, p = 0.094). GM volumes of the frontal cortex (r = 0.540, p = 0.011), caudate (r = 0.616, p = 0.002), and insula (r = 0.568, p = 0.007) were also Significantly correlated with MoCA, as were values of the insula (r = 0.508, p = 0.018), thalamus (r = 0.478, p = 0.028), and posterior cingulate cortex (PCC) (r = 0.472, p = 0.030).
Whole-cortex atrophy is associated with cognitive dysfunction, and this effect is larger than for cortical hypometabolism as measured with [F]FDG PET. At the regional level, focal atrophy and/or hypometabolism in the frontal lobe, insula, PCC, thalamus, and caudate seem to imply the importance of these regions for the decline of cognitive function in FTD. Furthermore, these results highlight how functional and structural changes may not overlap and might contribute to cognitive dysfunction in FTD in different ways. Our findings provide insight into the relationships between structural, metabolic, and cognitive changes due to FTD.
额颞叶痴呆(FTD)是一种临床和病理表现均具有异质性的疾病,在65岁以下患者中的患病率与阿尔茨海默病相当。灰质(GM)萎缩和葡萄糖代谢减低是FTD诊断及疾病进展评估的重要生物标志物。然而,仅有有限的研究在同一患者群体中使用不同成像方式系统地研究了FTD患者认知与神经影像学之间的关联。
我们在21例诊断为FTD的患者中,使用蒙特利尔认知评估量表(MoCA)评估认知情况,并采用结构磁共振成像(MRI)和F-氟脱氧葡萄糖正电子发射断层扫描([F]FDG PET)检测GM体积及葡萄糖代谢情况。以脑干作为参考区域计算标准化摄取值比()作为[F]FDG PET的主要观察指标。对PET数据应用部分容积校正以校正与疾病相关的萎缩。
全脑皮质GM体积与MoCA评分之间存在显著正相关(r = 0.461,p = 0.035)。全脑皮质[F]FDG与MoCA评分之间的关联不显著(r = 0.374,p = 0.094)。额叶皮质(r = 0.540,p = 0.011)、尾状核(r = 0.616,p = 0.002)和岛叶(r = 0.568,p = 0.007)的GM体积也与MoCA显著相关,岛叶(r = 0.508,p = 0.018)、丘脑(r = 0.478,p = 0.028)和后扣带回皮质(PCC)(r = 0.472,p = 0.030)的标准化摄取值比也与MoCA显著相关。
全脑皮质萎缩与认知功能障碍相关,且这种影响大于[F]FDG PET所测量的皮质代谢减低。在区域水平上,额叶、岛叶、PCC、丘脑和尾状核的局灶性萎缩和/或代谢减低似乎提示这些区域在FTD认知功能下降中具有重要作用。此外,这些结果突出了功能和结构变化可能并不重叠,且可能以不同方式导致FTD患者的认知功能障碍。我们的研究结果为FTD导致的结构、代谢和认知变化之间的关系提供了见解。